PL2531172T3 - Kompozycja farmaceutyczna o działaniu przeciw otyłości zawierająca mieszaninę wstępną czystego orlistatu i sposób przygotowania - Google Patents

Kompozycja farmaceutyczna o działaniu przeciw otyłości zawierająca mieszaninę wstępną czystego orlistatu i sposób przygotowania

Info

Publication number
PL2531172T3
PL2531172T3 PL10709955T PL10709955T PL2531172T3 PL 2531172 T3 PL2531172 T3 PL 2531172T3 PL 10709955 T PL10709955 T PL 10709955T PL 10709955 T PL10709955 T PL 10709955T PL 2531172 T3 PL2531172 T3 PL 2531172T3
Authority
PL
Poland
Prior art keywords
premixture
pharmaceutical composition
preparation process
obesity activity
pure orlistat
Prior art date
Application number
PL10709955T
Other languages
English (en)
Inventor
Mario Atilio Los
Original Assignee
Laboratorios Bagó S.A.
Eastbrand Holding Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43126897&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2531172(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratorios Bagó S.A., Eastbrand Holding Gmbh filed Critical Laboratorios Bagó S.A.
Publication of PL2531172T3 publication Critical patent/PL2531172T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/282Organic compounds, e.g. fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
PL10709955T 2010-02-01 2010-02-01 Kompozycja farmaceutyczna o działaniu przeciw otyłości zawierająca mieszaninę wstępną czystego orlistatu i sposób przygotowania PL2531172T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2010/000579 WO2011091816A1 (en) 2010-02-01 2010-02-01 Pharmaceutical composition with anti-obesity activity comprising a premixture of pure orlistat and preparation process

Publications (1)

Publication Number Publication Date
PL2531172T3 true PL2531172T3 (pl) 2017-07-31

Family

ID=43126897

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10709955T PL2531172T3 (pl) 2010-02-01 2010-02-01 Kompozycja farmaceutyczna o działaniu przeciw otyłości zawierająca mieszaninę wstępną czystego orlistatu i sposób przygotowania

Country Status (12)

Country Link
US (1) US8685449B2 (pl)
EP (1) EP2531172B1 (pl)
CN (1) CN102740831B (pl)
AR (1) AR078940A1 (pl)
BR (1) BR112012018696B1 (pl)
CL (1) CL2012002077A1 (pl)
ES (1) ES2609018T3 (pl)
MX (1) MX2012008861A (pl)
PL (1) PL2531172T3 (pl)
UA (1) UA107369C2 (pl)
WO (1) WO2011091816A1 (pl)
ZA (1) ZA201205769B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102552168B (zh) * 2012-01-31 2013-08-07 杭州华东医药集团生物工程研究所有限公司 一种含有奥利司他的药物组合物及其制备方法
CN106309565A (zh) * 2015-06-29 2017-01-11 北京海吉星医疗科技有限公司 一种贞芪扶正缓释滴丸及其制备方法
RU2762552C2 (ru) * 2020-10-05 2021-12-21 Общество с ограниченной ответственностью "Гротекс" (ООО "Гротекс") Фармацевтическая композиция оксиэтиламмония метилфеноксиацетата

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI54811C (fi) 1972-06-03 1979-03-12 Vega Jose Manuel Regife Foerfarande foer tillvaratagning och rening av zink fraon zinkhaltiga loesningar
CA1247547A (en) 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
AR025609A1 (es) 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones lipidas solidas
US20060246141A1 (en) * 2005-04-12 2006-11-02 Elan Pharma International, Limited Nanoparticulate lipase inhibitor formulations
WO2009044380A2 (en) 2007-10-05 2009-04-09 Ranbaxy Laboratories Limited Formulations containing orlistat particles having controlled particle size
PL216542B1 (pl) 2008-03-20 2014-04-30 Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna Sposób wytwarzania stabilnej kompozycji orlistatu w postaci kapsułkowanego proszku

Also Published As

Publication number Publication date
CL2012002077A1 (es) 2012-12-07
AR078940A1 (es) 2011-12-14
WO2011091816A1 (en) 2011-08-04
UA107369C2 (en) 2014-12-25
CN102740831B (zh) 2015-01-28
ES2609018T3 (es) 2017-04-18
BR112012018696B1 (pt) 2019-07-02
BR112012018696A2 (pt) 2016-05-03
EP2531172B1 (en) 2016-10-12
CN102740831A (zh) 2012-10-17
US20120294941A1 (en) 2012-11-22
ZA201205769B (en) 2013-04-24
US8685449B2 (en) 2014-04-01
MX2012008861A (es) 2013-08-29
EP2531172A1 (en) 2012-12-12

Similar Documents

Publication Publication Date Title
ZA201300002B (en) Novel processes for the preparation of phenylcyclopropylamine derivatives and use thereof for preparing ticagrelor
EP2536397A4 (en) SOLID PHARMACEUTICAL COMPOSITION COMPRISING ACTIVATORS AND METHODS FOR PREPARING THE SAME
GB201110850D0 (en) Catalyst and mehtod of preparation
IL230855A0 (en) Cabazitaxel formulations and methods for their preparation
PL2643010T3 (pl) Biologicznie aktywny kompleks i jego otrzymywanie
GB2478849A8 (en) Improved pharmaceutical compositions and methods of delivery
IL222576A0 (en) Fexofenadine-based composition and preparation process therefor
IL233290A0 (en) Preparation composition, and use of dense chitosan membrane materials
EP2647624A4 (en) SITAGLIPTIN INTERMEDIATES AND PROCESS FOR PREPARING THEM
EP2718331A4 (en) N, N, N-TRIALKYL POLYMERS, METHODS FOR THEIR PREPARATION, AND USES THEREOF
EP2766375A4 (en) PREPARATION OF NEW FLUORIN COMPOUNDS, METHOD OF MANUFACTURING AND COMPOSITIONS MADE THEREOF
HRP20170691T1 (hr) Polimerni konjugati djelatnih tvari, njihov postupak dobivanja i njihovi polimerni intermedijeri
HK1198939A1 (en) Pharmaceutical preparation comprising brexpiprazole and substituted beta - cyclodextrin brexpiprazole -
EP2581369A4 (en) METHOD OF MANUFACTURING DRONEDARON AND ITS SALTS
EP2608773A4 (en) FORMULATION AND MANUFACTURE OF PHARMACEUTICAL PRODUCTS BY IMPREGNATING ON POROUS SUBSTRATES
HK1188791A1 (zh) 新型八氫噻吩並喹啉衍生物、包含所述衍生物的藥物組合物及它們的用途
IL231505B (en) Pharmaceutical preparation and method for its production
EP2734513A4 (en) INTERMEDIATE PRODUCT OF STATIN MEDICINES AND THEIR MANUFACTURE
EP2701689A4 (en) PHARMACEUTICAL COMPOSITIONS OF RALTEEGRAVIR, METHODS OF PREPARATION AND USE THEREOF
ZA201205769B (en) Pharmaceutical composition with anti-obesity activity comprising a premixture of pure orlistat and preparation process
HRP20180781T1 (hr) Farmaceutski pripravak koji sadržava lidipidipin i proces pripreme
EP2640674B8 (en) Manner of obtainment of mass for production of shaped construction elements and mass for production of shaped construction elements
AU2010905364A0 (en) Production of serrulatane diterpenes and analogues
AU2010900810A0 (en) Production of serrulatane diterpenes and analogues
GB201112578D0 (en) Pharmaceutical preparation and use